Source: International Congress 2017 – Clinical points to ponder in asthma
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Worsley (Stevenage, Hertfordshire, United Kingdom). A novel hybrid approach to real-world data capture in a mepolizumab study. 628

Member's Comments

No comment yet.

Related content which might interest you: Time to change the single-centre approach to management of patients with tuberculosis: a novel network platform with automatic data import and data sharing Source: ERJ Open Res, 4 (1) 00108-2017; 10.1183/23120541.00108-2017 Year: 2018 A data management and analysis platform for RASP-UK multiomics clinical datasets Source: Virtual Congress 2021 – Exacerbations of chronic respiratory diseases, including SARS-CoV-2 Year: 2021 Indacaterol dose selection: utilising an adaptive seamless design in a clinical study in COPD Source: Annual Congress 2009 - Next generation bronchodilators Year: 2009 The optimal study design for identifying gene-environment interaction effects in large-scale studies Source: International Congress 2018 – Gene-environment interactions in the omics era Year: 2018 Defining successful NIV setup: data from a real-life cohort Source: Virtual Congress 2021 – Home mechanical ventilation: organisation and outcomes Year: 2021 Assessing the feasibility of GSK’s clinical genetic data re-use for drug target identification and validation: A respiratory case study Source: International Congress 2017 – Asthma genetics and genomics in patients and populations Year: 2017 Utilising data from single cell approaches to study existing and recently emerging lung diseases? Source: Virtual Congress 2021 – Utilising data from single cell approaches to study existing and recently emerging lung diseases? Year: 2021 Establishment of an integrated clinical network and comprehensive data warehouse for the conduct of comparative effectiveness research in COPD Source: Annual Congress 2011 - COPD: integrated care and rehabilitation Year: 2011 Use of a novel Bayesian borrowing statistical method to assess efficacy of mepolizumab in adolescents Source: Virtual Congress 2020 – Paediatric asthma Year: 2020 Assessment of a responder identification treatment algorithm for omalizumab in a naturalistic setting Source: Annual Congress 2007 - Improving asthma therapy - new findings in established and experimental treatment modalities Year: 2007 From research question to dissemination: how to design, analyse and present study results Source: Breathe, 14 (3) 232; 10.1183/20734735.020018 Year: 2018 Can locus of control become a useful indicator for a multicentre study: data from the Edu-Care® study Source: Eur Respir J 2002; 20: Suppl. 38, 263s Year: 2002 COVID-19 conundrum: clinical phenotyping based on pathophysiology as a promising approach to guide therapy in a novel illness Source: Eur Respir J, 56 (2) 2002135; 10.1183/13993003.02135-2020 Year: 2020 The impact of a new recruitment strategy to improve recruitment of participants to research studies Source: International Congress 2019 – How to guide patients to reach a balance between costs and personal needs: quality indicators of effectiveness Year: 2019 A pooling based genome-wide analysis identifies new potential candidate genes for atopy in the echrs study Source: Annual Congress 2009 - Asthma genetics: from genome wide to single nucleotide polymorphisms Year: 2009 To explore mechanisms in obesity-associated asthma using functional proteomics technology: A pilot study Source: International Congress 2017 – Novel mechanisms in asthma Year: 2017 Real-world mepolizumab in the prospective severe asthma REALITI-A study: initial analysis Source: Eur Respir J, 56 (4) 2000151; 10.1183/13993003.00151-2020 Year: 2020 Smartphone-based cough detection predicts asthma control – description of a novel, scalable digital biomarker Source: Virtual Congress 2020 – Chronic cough: only symptom or disease? Year: 2020 Where do we stand with asthma phenotypes derived from data-driven methods? A systematic review Source: International Congress 2019 – Respiratory function assessment in disease Year: 2019